BR0003972A - New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions - Google Patents

New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions

Info

Publication number
BR0003972A
BR0003972A BR0003972-1A BR0003972A BR0003972A BR 0003972 A BR0003972 A BR 0003972A BR 0003972 A BR0003972 A BR 0003972A BR 0003972 A BR0003972 A BR 0003972A
Authority
BR
Brazil
Prior art keywords
extract
new compound
compound isolated
drug compositions
guignardia
Prior art date
Application number
BR0003972-1A
Other languages
Portuguese (pt)
Inventor
Katia Ferreira Rodri Heerklotz
Joerg Arno Heerklotz
Christa Werner
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority to BR0003972-1A priority Critical patent/BR0003972A/en
Priority to US09/918,717 priority patent/US6544524B2/en
Priority to EP01959996A priority patent/EP1318824B1/en
Priority to AU2001281613A priority patent/AU2001281613A1/en
Priority to DE60109465T priority patent/DE60109465D1/en
Priority to AT01959996T priority patent/ATE290875T1/en
Priority to PCT/BR2001/000110 priority patent/WO2002017937A1/en
Priority to IT2001MI001837A priority patent/ITMI20011837A1/en
Publication of BR0003972A publication Critical patent/BR0003972A/en
Priority to US10/369,761 priority patent/US20030165532A1/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"NOVO COMPOSTO ISOLADO DO EXTRATO DO FUNGO GUIGNARDIA SP. E SEU USO EM COMPOSIçõES MEDICAMENTOSAS". A presente invenção apresenta uma nova molécula contendo um anel dioxolanona, ou um sal do mesmo, possuindo a seguinte fórmula: A invenção apresenta ainda uma composição farmacêutica para ser usada no tratamento de infecções microbianas, preferencialmente no tratamento de doenças causadas por fungos e bactérias."NEW COMPOUND ISOLATED FROM THE FUNGUS EXTRACT GUIGNARDIA SP. AND ITS USE IN MEDICINAL COMPOSITIONS". The present invention features a new molecule containing a dioxolanone ring, or a salt thereof, having the following formula: The invention also features a pharmaceutical composition to be used in the treatment of microbial infections, preferably in the treatment of diseases caused by fungi and bacteria.

BR0003972-1A 2000-09-01 2000-09-01 New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions BR0003972A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BR0003972-1A BR0003972A (en) 2000-09-01 2000-09-01 New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions
US09/918,717 US6544524B2 (en) 2000-09-01 2001-08-01 Ethyl acetate extract from guignardia used to treat an individual infected by fungi or bacteria
EP01959996A EP1318824B1 (en) 2000-09-01 2001-08-29 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
AU2001281613A AU2001281613A1 (en) 2000-09-01 2001-08-29 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
DE60109465T DE60109465D1 (en) 2000-09-01 2001-08-29 EXTRACTS OF THE MUSHROOM GUIGNARDIA SP., THEIR USE IN PHARMACEUTICAL COMPOUNDS; NEW ISOLATED CONNECTION FROM GUIGNARDIA SP. MUSHROOM EXTRACTS AND THEIR USE IN PHARMACEUTICAL PREPARATIONS
AT01959996T ATE290875T1 (en) 2000-09-01 2001-08-29 EXTRACTS OF THE MUSHROOM GUIGNARDIA SP., THE USE THEREOF IN PHARMACEUTICAL COMPOUNDS; NEWLY INSULATED CONNECTION MADE OF GUIGNARDIA SP. MUSHROOM EXTRACTS AND THEIR USE IN PHARMACEUTICAL PREPARATIONS
PCT/BR2001/000110 WO2002017937A1 (en) 2000-09-01 2001-08-29 Extracts from the fungus guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus guignardia sp. and its use in pharmaceutical compositions
IT2001MI001837A ITMI20011837A1 (en) 2000-09-01 2001-08-31 EXTRACTS FROM FUNGUS GUIGNARDIA SP., THEIR USE IN PHARMACEUTICAL COMPOSITIONS, NEW COMPOUND ISOLATED FROM THE FUNGUS GUIGNARDIA EXTRACT
US10/369,761 US20030165532A1 (en) 2000-09-01 2003-02-21 Extracts from the fungus Guignardia sp., their uses in pharmaceutical compositions, new isolate compound from the extract of the fungus Gignardia sp. and its use in pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0003972-1A BR0003972A (en) 2000-09-01 2000-09-01 New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions

Publications (1)

Publication Number Publication Date
BR0003972A true BR0003972A (en) 2002-04-16

Family

ID=3945141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0003972-1A BR0003972A (en) 2000-09-01 2000-09-01 New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions

Country Status (1)

Country Link
BR (1) BR0003972A (en)

Similar Documents

Publication Publication Date Title
SE0001899D0 (en) New compounds
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
BR0012674A (en) Preserved pharmaceutical formulations
SE0300010D0 (en) Novel Compounds
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
BR0000003A (en) Azalides and methods of preparing them
NO20063277L (en) Pharmaceutical composition of vinflunine intended for parenteral administration, preparation and use thereof
HUP0102515A2 (en) Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DE60024857D1 (en) NEW CONNECTIONS
BRPI0409818A (en) compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
PT1414467E (en) TOP TREATMENT OF MASTALGIA
BRPI0409878A (en) compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
BRPI0409881A (en) compounds, pharmaceutical compositions, method for the treatment or prophylaxis of diseases, and uses of compounds and one or more compounds in combination with other pharmacologically active compounds
BR0006301A (en) Antibacterial and prokinetic macrolides
BR0309878A (en) Heterotricyclyl-6-alkylidene penenes as beta-lactamase inhibitors
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BRPI0413684A (en) compounds, pharmaceutical composition and methods of preparation, treatment of microbial infection and extermination of microorganism and uses
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
DE50113974D1 (en) COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYLPHOSPHONIC ACID DERIVATIVES WITH SPECIAL PHARMACEUTICAL ACTIVE SUBSTANCES
BR0003972A (en) New compound isolated from the extract of the fungus guignardia sp. and its use in drug compositions
DE602004017586D1 (en) MEDICAL COMPOSITION FOR THE TREATMENT OF INFECTIONS WITH DRUG-RESISTANT STAPHYLOCOCCUS AUREUS

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7AANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.